KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 134 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 5.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $102,291 | -83.7% | 57,146 | -6.0% | 0.00% | -66.7% |
| Q2 2021 | $627,000 | -93.9% | 60,786 | -93.8% | 0.00% | -94.6% |
| Q1 2021 | $10,314,000 | -32.0% | 980,464 | 0.0% | 0.06% | -52.1% |
| Q4 2020 | $15,178,000 | +594.3% | 980,464 | +554.7% | 0.12% | +350.0% |
| Q3 2020 | $2,186,000 | +1038.5% | 149,752 | +1397.5% | 0.03% | +1200.0% |
| Q1 2020 | $192,000 | -77.3% | 10,000 | -45.1% | 0.00% | -88.9% |
| Q2 2014 | $847,000 | – | 18,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |